November 23, 2016 - By Darrin Black · 0 Comments
Nov 23 is a negative day so far for PowerShares Dynamic Pharmaceuticals ETF (NYSEARCA:PJP) as the ETF is active during the day after losing 0.23% to hit $57.05 per share. The exchange traded fund has 890.08 million net assets and 1.79% volatility this month.
Over the course of the day 32,045 shares traded hands, as compared to an average volume of 146,600 over the last 30 days for PowerShares Dynamic Pharmaceuticals ETF (NYSEARCA:PJP).
The ETF is -16.84% of its 52-Week High and 10.40% of its low, and is currently having ATR of 1.3. This year’s performance is -15.10% while this quarter’s performance is -11.39%.
The ETF’s YTD performance is -18.99%, the 1 year is -15.44% and the 3 year is 8.77%.
The ETF’s average P/E ratio is 16.59, the price to book is 2.13, the price to sales is 3.18 and the price to cashflow is 10.71. It was started on 6/23/2005. The fund’s top holdings are: Johnson & Johnson Common Stock for 5.59% of assets, Celgene Corporation for 5.41%, Merck & Company Inc. Common St for 5.38%, Gilead Sciences Inc. for 5.25%, Pfizer Inc. Common Stock for 5.21%, Depomed Inc. for 5.17%, Allergan plc Ordinary Shares for 5.05%, Bristol-Myers Squibb Company Co for 4.95%, Amgen Inc. for 4.74%, Baxter International Inc. Commo for 4.62%. The ETF sector weights are: Healthcare 100.00%. The ETF currently as 0.76% yield.
More notable recent PowerShares Dynamic Pharmaceuticals(ETF) (NYSEARCA:PJP) news were published by: Etfdailynews.com which released: “Are Pharmaceutical Stocks In Trouble?” on September 20, 2016, also Seekingalpha.com with their article: “PJP: Will Big Pharma Continue To Outperform In 2016?” published on December 28, 2015, Seekingalpha.com published: “PowerShares Dynamic Pharmaceuticals ETF: Big Pharma Looks Abroad to Continue …” on March 11, 2013. More interesting news about PowerShares Dynamic Pharmaceuticals(ETF) (NYSEARCA:PJP) were released by: Seekingalpha.com and their article: “A Prescription For High Risk Fever” published on May 03, 2016 as well as Forbes.com‘s news article titled: “Two Health Care ETFs With The Most Growth Potential: S&P Capital IQ” with publication date: May 07, 2015.
PowerShares Dynamic Pharmaceuticals Portfolio is a non-diversified fund. The ETF has a market cap of $890.08 million. The Fund seeks investment results that correspond generally to the price and yield of the Dynamic Pharmaceuticals Intellidex Index (the Index). It has a 3.59 P/E ratio. The Index evaluates companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.
By Darrin Black